Business Standard

Monday, December 23, 2024 | 02:24 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Orchid Pharma Ltd sees net loss narrowing to Rs 13.44 crore in Q4

The company has been under Corporate Insolvency Resolution Process (CIRP) and the Resolution Professional has received three resolution plans from prospective bidders

Orchid Pharma
Premium

Orchid Pharma

BS Reporter Chennai
BS Reporter
Chennai, 3 June

Orchid Pharma Ltd has seen its net loss narrowing to Rs 13.44 crore during the quarter ended March 31, 2019, as compared to a net loss of Rs 92.37 crore during the same period last year. The total income grew to Rs 166.55 crore as compared to Rs 157.20 crore during the corresponding quarter of the previous fiscal. 

The company has been under Corporate Insolvency Resolution Process (CIRP) and the Resolution Professional has received three resolution plans from prospective bidders, which will now be considered by the Committee of Creditors (CoC). The National Company Law Tribunal had earlier

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in